FORMA Therapeutics, Inc. Launches New Collaborative Framework to Transform Basic Research Into Promising Therapies
6/18/2013 9:31:45 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics announced today its Asset Discovery and Development Company (“ADDCo”) platform, an initiative in which FORMA will join forces with select academic, not-for-profit and venture philanthropy institutions to transform basic research discoveries into life-saving therapies. The creation of a virtual ADDCo brings together academic thought leaders with FORMA’s ultra-efficient drug discovery engine and world class development network to rapidly execute on a compelling area of science. The ADDCos will span multiple therapeutic areas with the near term focus being oncology and rare genetic disorders.
Help employers find you! Check out all the jobs and post your resume.